IRON Latest Headlines

Analysts’ Top Healthcare Picks: Asahi Intecc Co (AHICF), Disc Medicine (IRON)

at www.tipranks.com (Fri, 13-Nov 11:50 AM)

Analysts Offer Insights on Healthcare Companies: InMed Pharmaceuticals (INM), Disc Medicine (IRON) and Radnet (RDNT)

at www.tipranks.com (Tue, 10-Nov 3:20 AM)

Analysts Offer Insights on Healthcare Companies: Disc Medicine (IRON) and Immunic (IMUX)

at www.tipranks.com (Mon, 9-Nov 5:40 AM)

Disc Medicine’s Complementary Blood-Disorder Portfolio Supports Buy Rating and $132 Price Target

at www.tipranks.com (Mon, 9-Nov 4:26 AM)

Disc Medicine prices a $450 million upsized stock offering at $75 as it funds bitopertin commercialization work

Market Chameleon (Wed, 21-Oct 8:38 AM)

IRON Jumps After Phase 3 APOLLO Trial Hits Every Primary and Secondary Endpoint for Bitopertin in EPP

Market Chameleon (Mon, 19-Oct 10:26 AM)

Disc Medicine (IRON) posts Phase 3 APOLLO win as bitopertin cuts PPIX 41.4% and adds 12.2 hours of pain-free light time

Market Chameleon (Mon, 19-Oct 7:06 AM)